Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-011078
Filing Date
2019-11-14
Accepted
2019-11-14 17:16:52
Documents
83
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q osmt-20190930x10q.htm 10-Q 2924761
2 EX-31.1 osmt-20190930ex311a603f7.htm EX-31.1 12657
3 EX-31.2 osmt-20190930ex31252f15e.htm EX-31.2 12627
4 EX-32.1 osmt-20190930ex321c15d5e.htm EX-32.1 10171
5 EX-32.2 osmt-20190930ex322755f86.htm EX-32.2 11259
  Complete submission text file 0001558370-19-011078.txt   11904906

Data Files

Seq Description Document Type Size
6 EX-101.INS osmt-20190930.xml EX-101.INS 3303053
7 EX-101.SCH osmt-20190930.xsd EX-101.SCH 54182
8 EX-101.CAL osmt-20190930_cal.xml EX-101.CAL 80536
9 EX-101.DEF osmt-20190930_def.xml EX-101.DEF 200205
10 EX-101.LAB osmt-20190930_lab.xml EX-101.LAB 487263
11 EX-101.PRE osmt-20190930_pre.xml EX-101.PRE 399838
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38709 | Film No.: 191221608
SIC: 2834 Pharmaceutical Preparations